249 related articles for article (PubMed ID: 29495092)
1. Tumour budding in pancreatic cancer revisited: validation of the ITBCC scoring system.
Karamitopoulou E; Wartenberg M; Zlobec I; Cibin S; Worni M; Gloor B; Lugli A
Histopathology; 2018 Jul; 73(1):137-146. PubMed ID: 29495092
[TBL] [Abstract][Full Text] [Related]
2. Tumor budding as a prognostic factor in pancreatic ductal adenocarcinoma.
Petrova E; Zielinski V; Bolm L; Schreiber C; Knief J; Thorns C; Bronsert P; Timme-Bronsert S; Bausch D; Perner S; Keck T; Wellner U
Virchows Arch; 2020 Apr; 476(4):561-568. PubMed ID: 31786688
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of Tumor Budding in Predicting Survival for Gastric Carcinoma Patients in Vietnam.
Dao TV; Nguyen CV; Nguyen QT; Vu HTN; Phung HT; Bui OT; Nguyen DK; Luong BV; Tran TV
Cancer Control; 2020; 27(1):1073274820968883. PubMed ID: 33136444
[TBL] [Abstract][Full Text] [Related]
4. Prognostic significance of tumour budding assessed in gastric carcinoma according to the criteria of the International Tumour Budding Consensus Conference.
Ulase D; Heckl S; Behrens HM; Krüger S; Röcken C
Histopathology; 2020 Feb; 76(3):433-446. PubMed ID: 31538348
[TBL] [Abstract][Full Text] [Related]
5. High c-Met expression in stage I-II pancreatic adenocarcinoma: proposal for an immunostaining scoring method and correlation with poor prognosis.
Neuzillet C; Couvelard A; Tijeras-Raballand A; de Mestier L; de Gramont A; Bédossa P; Paradis V; Sauvanet A; Bachet JB; Ruszniewski P; Raymond E; Hammel P; Cros J
Histopathology; 2015 Nov; 67(5):664-76. PubMed ID: 25809563
[TBL] [Abstract][Full Text] [Related]
6. Tumor budding is an independent prognostic factor in stage III colon cancer patients: a post-hoc analysis of the IDEA-France phase III trial (PRODIGE-GERCOR).
Basile D; Broudin C; Emile JF; Falcoz A; Pagès F; Mineur L; Bennouna J; Louvet C; Artru P; Fratte S; Ghiringhelli F; André T; Derangère V; Vernerey D; Taieb J; Svrcek M;
Ann Oncol; 2022 Jun; 33(6):628-637. PubMed ID: 35306156
[TBL] [Abstract][Full Text] [Related]
7. Validation of the International Tumor Budding Consensus Conference 2016 recommendations on tumor budding in stage I-IV colorectal cancer.
Dawson H; Galuppini F; Träger P; Berger MD; Studer P; Brügger L; Zlobec I; Inderbitzin D; Lugli A
Hum Pathol; 2019 Mar; 85():145-151. PubMed ID: 30428391
[TBL] [Abstract][Full Text] [Related]
8. Tumour budding is a strong and independent prognostic factor in pancreatic cancer.
Karamitopoulou E; Zlobec I; Born D; Kondi-Pafiti A; Lykoudis P; Mellou A; Gennatas K; Gloor B; Lugli A
Eur J Cancer; 2013 Mar; 49(5):1032-9. PubMed ID: 23177090
[TBL] [Abstract][Full Text] [Related]
9. Refining the ITBCC tumor budding scoring system with a "zero-budding" category in colorectal cancer.
Zlobec I; Bächli M; Galuppini F; Berger MD; Dawson HE; Nagtegaal ID; Lugli A
Virchows Arch; 2021 Dec; 479(6):1085-1090. PubMed ID: 33843013
[TBL] [Abstract][Full Text] [Related]
10. Tumour buds determine prognosis in resected pancreatic ductal adenocarcinoma.
Lohneis P; Sinn M; Klein F; Bischoff S; Striefler JK; Wislocka L; Sinn BV; Pelzer U; Oettle H; Riess H; Denkert C; Bläker H; Jühling A
Br J Cancer; 2018 May; 118(11):1485-1491. PubMed ID: 29755112
[TBL] [Abstract][Full Text] [Related]
11. Tumor budding is an independent adverse prognostic factor in pancreatic ductal adenocarcinoma.
O'Connor K; Li-Chang HH; Kalloger SE; Peixoto RD; Webber DL; Owen DA; Driman DK; Kirsch R; Serra S; Scudamore CH; Renouf DJ; Schaeffer DF
Am J Surg Pathol; 2015 Apr; 39(4):472-8. PubMed ID: 25634751
[TBL] [Abstract][Full Text] [Related]
12. Should a fourth category be added to the international tumor budding consensus conference tumor budding scoring system in colorectal adenocarcinomas?
Secinti IE; Ozgur T; Gursoy D; Dede I
APMIS; 2022 Sep; 130(9):560-567. PubMed ID: 35816469
[TBL] [Abstract][Full Text] [Related]
13. Reproducibility of tumor budding assessment in pancreatic cancer based on a multicenter interobserver study.
Karamitopoulou E; Esposito I; Zlobec I; Insilla AC; Wartenberg M; Schaeffer DF; Kalloger S; La Rosa S; Sempoux C; Ramos Centeno I; Lohneis P
Virchows Arch; 2021 Apr; 478(4):719-726. PubMed ID: 33330964
[TBL] [Abstract][Full Text] [Related]
14. Reporting of tumor budding in colorectal adenocarcinomas using ×40 objective: A practical approach for resource constrained set-ups.
Roy P; Datta J; Roy M; Mallick I; Mohandas M
Indian J Cancer; 2017; 54(4):640-645. PubMed ID: 30082550
[TBL] [Abstract][Full Text] [Related]
15. Prognostic value of tumour budding in stomach cancers.
Kucuk S
Int J Clin Pract; 2021 Dec; 75(12):e14922. PubMed ID: 34580963
[TBL] [Abstract][Full Text] [Related]
16. Prognostic and predictive values of tumour budding in stage IV colorectal cancer.
Nagata K; Shinto E; Yamadera M; Shiraishi T; Kajiwara Y; Okamoto K; Mochizuki S; Hase K; Kishi Y; Ueno H
BJS Open; 2020 Aug; 4(4):693-703. PubMed ID: 32472647
[TBL] [Abstract][Full Text] [Related]
17. pT but not pN stage of the 8th TNM classification significantly improves prognostication in pancreatic ductal adenocarcinoma.
Schlitter AM; Jesinghaus M; Jäger C; Konukiewitz B; Muckenhuber A; Demir IE; Bahra M; Denkert C; Friess H; Kloeppel G; Ceyhan GO; Weichert W
Eur J Cancer; 2017 Oct; 84():121-129. PubMed ID: 28802189
[TBL] [Abstract][Full Text] [Related]
18. Equipping the American Joint Committee on Cancer staging for resectable pancreatic ductal adenocarcinoma with tumor grade: a recursive partitioning analysis.
Chen YT; Huang ZP; Zhou ZW; He MM
Med Oncol; 2016 Nov; 33(11):122. PubMed ID: 27730526
[TBL] [Abstract][Full Text] [Related]
19. Comprehensive assessment of tumour budding by cytokeratin staining in colorectal cancer.
Rieger G; Koelzer VH; Dawson HE; Berger MD; Hädrich M; Inderbitzin D; Lugli A; Zlobec I
Histopathology; 2017 Jun; 70(7):1044-1051. PubMed ID: 28061021
[TBL] [Abstract][Full Text] [Related]
20. Validation of the International Tumor Budding Consensus Conference (ITBCC) 2016 recommendation in squamous cell carcinoma of the lung-a single-center analysis of 354 cases.
Neppl C; Zlobec I; Schmid RA; Berezowska S
Mod Pathol; 2020 May; 33(5):802-811. PubMed ID: 31796876
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
